MAXION THERAPEUTICS LIMITED

Active London

Other research and experimental development on natural sciences and engineering

39 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
M

MAXION THERAPEUTICS LIMITED

Other research and experimental development on natural sciences and engineering

Founded 16 Apr 2020 Active London, United Kingdom 39 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts Submitted 2 Apr 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 18 May 2026 Next due 24 May 2027 11 months remaining
Net assets £51M £46M 2025 year on year
Total assets £54M £48M 2025 year on year
Total Liabilities £3M £2M 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Mishcon De Reya, Africa House 70 Kingsway London WC2B 6AH United Kingdom

Website

www.example.com

Full company profile for MAXION THERAPEUTICS LIMITED (12560803), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 16 Apr 2020. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2020–2025)

Cash in Bank

£48.52M

Increased by £45.06M (+1304%)

Net Assets

£50.95M

Increased by £45.88M (+906%)

Total Liabilities

£2.84M

Increased by £2.10M (+282%)

Turnover

N/A

Employees

39

Increased by 9 (+30%)

Debt Ratio

5%

Decreased by 8 (-62%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2
Grants 1

Investors (7)

Investor NameInvestor SinceParticipating Rounds
Investor 1Feb 2023Seed, Series A
Investor 2Feb 2023Seed, Series A
Investor 3Feb 2023Seed, Series A

Share Capital

Share Capital

Share allotments and capital structure

11 Allotments 7,368,056 Shares £71.01m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
8 Dec 2025526,417£52.642£0
8 Dec 2025658£0.479£0.479
7 Mar 20255,102,324£58.06m£11.38
15 Jan 20251,130£0.479£0.479
14 Nov 2024940£0.479£0.479

Officers

Officers

2 active 1 resigned
Status
Funnell, Timothy MichaelDirectorBritishEngland393 Feb 2023Active
Jones, Lucy EdwardesDirectorBritishEngland333 Feb 2023Active

Shareholders

Shareholders (32)

General Catalyst Group Xii - Health Assurance, L.p
14.9%
1,169,283
John Mccafferty
11.5%
900,000

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

John Mccafferty

Ceased 7 Mar 2025

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Suite 4, The Works, West Street, Unity Campus, Pampisford, Cambridge (CB22 3FT) SOUTH CAMBRIDGESHIRE
Leasehold-13 Jul 2023
Suite 4, The Works, West Street, Unity Campus, Pampisford, Cambridge (CB22 3FT)
Leasehold
Added 13 Jul 2023
District SOUTH CAMBRIDGESHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
18 May 2026OfficersTermination of Emma Johnson as director on 11 Dec 2025
18 May 2026Confirmation StatementConfirmation statement made on 10 May 2026 with updates
2 Apr 2026AccountsAnnual accounts made up to 31 Dec 2025
23 Mar 2026CapitalAllotment of shares (GBP 836.8056) on 29 Dec 2025
23 Sept 2025OfficersAppointment of Santiago Arroyo as director on 17 Jul 2025
18 May 2026 Officers

Termination of Emma Johnson as director on 11 Dec 2025

18 May 2026 Confirmation Statement

Confirmation statement made on 10 May 2026 with updates

2 Apr 2026 Accounts

Annual accounts made up to 31 Dec 2025

23 Mar 2026 Capital

Allotment of shares (GBP 836.8056) on 29 Dec 2025

23 Sept 2025 Officers

Appointment of Santiago Arroyo as director on 17 Jul 2025

Recent Activity

Latest Activity

Termination of Emma Johnson as director on 11 Dec 2025

2 weeks ago on 18 May 2026

Confirmation statement made on 10 May 2026 with updates

2 weeks ago on 18 May 2026

Annual accounts made up to 31 Dec 2025

2 months ago on 2 Apr 2026

Allotment of shares (GBP 836.8056) on 29 Dec 2025

2 months ago on 23 Mar 2026

Appointment of Santiago Arroyo as director on 17 Jul 2025

8 months ago on 23 Sept 2025